"","ID","Description","GeneRatio","BgRatio","pvalue","p.adjust","qvalue","geneID","Count"
"R-HSA-198725","R-HSA-198725","Nuclear Events (kinase and transcription factor activation)","10/38","24/2914",6.84098558552061e-14,2.64062043601095e-11,1.37539815456256e-11,"MAPK3/MAPK14/RPS6KA3/MAPK11/PPP2CB/PPP2CA/MAPK1/RPS6KA5/PPP2R1B/MAPKAPK2",10
"R-HSA-450282","R-HSA-450282","MAPK targets/ Nuclear events mediated by MAP kinases","10/38","30/2914",9.93856827999852e-13,1.3414181286989e-10,6.98693380369483e-11,"MAPK3/MAPK14/RPS6KA3/MAPK11/PPP2CB/PPP2CA/MAPK1/RPS6KA5/PPP2R1B/MAPKAPK2",10
"R-HSA-198753","R-HSA-198753","ERK/MAPK targets","9/38","21/2914",1.04255294976598e-12,1.3414181286989e-10,6.98693380369483e-11,"MAPK3/MAPK14/RPS6KA3/MAPK11/PPP2CB/PPP2CA/MAPK1/RPS6KA5/PPP2R1B",9
"R-HSA-212436","R-HSA-212436","Generic Transcription Pathway","24/38","481/2914",9.90300487023829e-11,9.55639969977995e-09,4.97756297425135e-09,"MAPK3/CTNNB1/GSK3B/MEN1/MAPK14/MAX/RARA/NR0B2/SIRT1/SMAD3/CSNK2A1/SMAD1/TGFB1/PCGF2/MAPK11/E2F4/PPP2CB/UBE2I/YY1/SMAD2/PPP2CA/MAPK1/PRKACA/PPP2R1B",24
"R-HSA-73857","R-HSA-73857","RNA Polymerase II Transcription","24/38","499/2914",2.21348350689093e-10,1.7088092673198e-08,8.90053368034037e-09,"MAPK3/CTNNB1/GSK3B/MEN1/MAPK14/MAX/RARA/NR0B2/SIRT1/SMAD3/CSNK2A1/SMAD1/TGFB1/PCGF2/MAPK11/E2F4/PPP2CB/UBE2I/YY1/SMAD2/PPP2CA/MAPK1/PRKACA/PPP2R1B",24
"R-HSA-450294","R-HSA-450294","MAP kinase activation","10/38","60/2914",1.91083591024245e-09,1.22930443558931e-07,6.40297647116331e-08,"MAPK3/MAPK14/RPS6KA3/MAPK11/PPP2CB/PPP2CA/MAPK1/RPS6KA5/PPP2R1B/MAPKAPK2",10
"R-HSA-448424","R-HSA-448424","Interleukin-17 signaling","10/38","64/2914",3.70456704575772e-09,2.04280411380354e-07,1.06401850487177e-07,"MAPK3/MAPK14/RPS6KA3/MAPK11/PPP2CB/PPP2CA/MAPK1/RPS6KA5/PPP2R1B/MAPKAPK2",10
"R-HSA-4839743","R-HSA-4839743","phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex","6/38","14/2914",9.08376718295449e-09,2.53555553650445e-07,1.3206738682093e-07,"CTNNB1/GSK3B/PPP2CB/PPP2CA/AMER1/PPP2R1B",6
"R-HSA-5339716","R-HSA-5339716","Misspliced GSK3beta mutants stabilize beta-catenin","6/38","14/2914",9.08376718295449e-09,2.53555553650445e-07,1.3206738682093e-07,"CTNNB1/GSK3B/PPP2CB/PPP2CA/AMER1/PPP2R1B",6
"R-HSA-5358747","R-HSA-5358747","S33 mutants of beta-catenin aren't phosphorylated","6/38","14/2914",9.08376718295449e-09,2.53555553650445e-07,1.3206738682093e-07,"CTNNB1/GSK3B/PPP2CB/PPP2CA/AMER1/PPP2R1B",6
"R-HSA-5358749","R-HSA-5358749","S37 mutants of beta-catenin aren't phosphorylated","6/38","14/2914",9.08376718295449e-09,2.53555553650445e-07,1.3206738682093e-07,"CTNNB1/GSK3B/PPP2CB/PPP2CA/AMER1/PPP2R1B",6
"R-HSA-5358751","R-HSA-5358751","S45 mutants of beta-catenin aren't phosphorylated","6/38","14/2914",9.08376718295449e-09,2.53555553650445e-07,1.3206738682093e-07,"CTNNB1/GSK3B/PPP2CB/PPP2CA/AMER1/PPP2R1B",6
"R-HSA-5358752","R-HSA-5358752","T41 mutants of beta-catenin aren't phosphorylated","6/38","14/2914",9.08376718295449e-09,2.53555553650445e-07,1.3206738682093e-07,"CTNNB1/GSK3B/PPP2CB/PPP2CA/AMER1/PPP2R1B",6
"R-HSA-187037","R-HSA-187037","Signaling by NTRK1 (TRKA)","10/38","70/2914",9.19631541737365e-09,2.53555553650445e-07,1.3206738682093e-07,"MAPK3/MAPK14/RPS6KA3/MAPK11/PPP2CB/PPP2CA/MAPK1/RPS6KA5/PPP2R1B/MAPKAPK2",10
"R-HSA-196299","R-HSA-196299","Beta-catenin phosphorylation cascade","6/38","16/2914",2.3768193196516e-08,5.82362084904769e-07,3.03330128761415e-07,"CTNNB1/GSK3B/PPP2CB/PPP2CA/AMER1/PPP2R1B",6
"R-HSA-168142","R-HSA-168142","Toll Like Receptor 10 (TLR10) Cascade","10/38","78/2914",2.71567811613623e-08,5.82362084904769e-07,3.03330128761415e-07,"MAPK3/MAPK14/RPS6KA3/MAPK11/PPP2CB/PPP2CA/MAPK1/RPS6KA5/PPP2R1B/MAPKAPK2",10
"R-HSA-168176","R-HSA-168176","Toll Like Receptor 5 (TLR5) Cascade","10/38","78/2914",2.71567811613623e-08,5.82362084904769e-07,3.03330128761415e-07,"MAPK3/MAPK14/RPS6KA3/MAPK11/PPP2CB/PPP2CA/MAPK1/RPS6KA5/PPP2R1B/MAPKAPK2",10
"R-HSA-975871","R-HSA-975871","MyD88 cascade initiated on plasma membrane","10/38","78/2914",2.71567811613623e-08,5.82362084904769e-07,3.03330128761415e-07,"MAPK3/MAPK14/RPS6KA3/MAPK11/PPP2CB/PPP2CA/MAPK1/RPS6KA5/PPP2R1B/MAPKAPK2",10
"R-HSA-975138","R-HSA-975138","TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation","10/38","83/2914",5.01961358179711e-08,1.01977412767036e-06,5.31161326384071e-07,"MAPK3/MAPK14/RPS6KA3/MAPK11/PPP2CB/PPP2CA/MAPK1/RPS6KA5/PPP2R1B/MAPKAPK2",10
"R-HSA-168181","R-HSA-168181","Toll Like Receptor 7/8 (TLR7/8) Cascade","10/38","84/2914",5.64711788031993e-08,1.03799404847785e-06,5.40651386035643e-07,"MAPK3/MAPK14/RPS6KA3/MAPK11/PPP2CB/PPP2CA/MAPK1/RPS6KA5/PPP2R1B/MAPKAPK2",10
"R-HSA-975155","R-HSA-975155","MyD88 dependent cascade initiated on endosome","10/38","84/2914",5.64711788031993e-08,1.03799404847785e-06,5.40651386035643e-07,"MAPK3/MAPK14/RPS6KA3/MAPK11/PPP2CB/PPP2CA/MAPK1/RPS6KA5/PPP2R1B/MAPKAPK2",10
"R-HSA-1266738","R-HSA-1266738","Developmental Biology","19/38","397/2914",6.97177497523792e-08,1.09811714361161e-06,5.71967205971687e-07,"MAPK3/CTNNB1/GSK3B/MAPK14/RARA/SMAD3/CSNK2A1/RPS6KA3/TGFB1/PCGF2/MAPK11/YY1/SMAD2/MAPK1/RPS6KA5/PAX6/PRKACA/TDGF1/RPS6KA4",19
"R-HSA-166058","R-HSA-166058","MyD88:MAL(TIRAP) cascade initiated on plasma membrane","10/38","86/2914",7.11352108855793e-08,1.09811714361161e-06,5.71967205971687e-07,"MAPK3/MAPK14/RPS6KA3/MAPK11/PPP2CB/PPP2CA/MAPK1/RPS6KA5/PPP2R1B/MAPKAPK2",10
"R-HSA-168138","R-HSA-168138","Toll Like Receptor 9 (TLR9) Cascade","10/38","86/2914",7.11352108855793e-08,1.09811714361161e-06,5.71967205971687e-07,"MAPK3/MAPK14/RPS6KA3/MAPK11/PPP2CB/PPP2CA/MAPK1/RPS6KA5/PPP2R1B/MAPKAPK2",10
"R-HSA-168188","R-HSA-168188","Toll Like Receptor TLR6:TLR2 Cascade","10/38","86/2914",7.11352108855793e-08,1.09811714361161e-06,5.71967205971687e-07,"MAPK3/MAPK14/RPS6KA3/MAPK11/PPP2CB/PPP2CA/MAPK1/RPS6KA5/PPP2R1B/MAPKAPK2",10
"R-HSA-168164","R-HSA-168164","Toll Like Receptor 3 (TLR3) Cascade","10/38","87/2914",7.9656165857837e-08,1.09811714361161e-06,5.71967205971687e-07,"MAPK3/MAPK14/RPS6KA3/MAPK11/PPP2CB/PPP2CA/MAPK1/RPS6KA5/PPP2R1B/MAPKAPK2",10
"R-HSA-168179","R-HSA-168179","Toll Like Receptor TLR1:TLR2 Cascade","10/38","87/2914",7.9656165857837e-08,1.09811714361161e-06,5.71967205971687e-07,"MAPK3/MAPK14/RPS6KA3/MAPK11/PPP2CB/PPP2CA/MAPK1/RPS6KA5/PPP2R1B/MAPKAPK2",10
"R-HSA-181438","R-HSA-181438","Toll Like Receptor 2 (TLR2) Cascade","10/38","87/2914",7.9656165857837e-08,1.09811714361161e-06,5.71967205971687e-07,"MAPK3/MAPK14/RPS6KA3/MAPK11/PPP2CB/PPP2CA/MAPK1/RPS6KA5/PPP2R1B/MAPKAPK2",10
"R-HSA-166520","R-HSA-166520","Signaling by NTRKs","10/38","89/2914",9.94443529223696e-08,1.32363862855292e-06,6.89432718989931e-07,"MAPK3/MAPK14/RPS6KA3/MAPK11/PPP2CB/PPP2CA/MAPK1/RPS6KA5/PPP2R1B/MAPKAPK2",10
"R-HSA-166166","R-HSA-166166","MyD88-independent TLR4 cascade ","10/38","90/2914",1.10875641214921e-07,1.38058056480514e-06,7.19091594976225e-07,"MAPK3/MAPK14/RPS6KA3/MAPK11/PPP2CB/PPP2CA/MAPK1/RPS6KA5/PPP2R1B/MAPKAPK2",10
"R-HSA-937061","R-HSA-937061","TRIF(TICAM1)-mediated TLR4 signaling ","10/38","90/2914",1.10875641214921e-07,1.38058056480514e-06,7.19091594976225e-07,"MAPK3/MAPK14/RPS6KA3/MAPK11/PPP2CB/PPP2CA/MAPK1/RPS6KA5/PPP2R1B/MAPKAPK2",10
"R-HSA-202670","R-HSA-202670","ERKs are inactivated","5/38","12/2914",2.13169921343866e-07,2.57136217621038e-06,1.33932417686442e-06,"MAPK3/PPP2CB/PPP2CA/MAPK1/PPP2R1B",5
"R-HSA-4839735","R-HSA-4839735","AXIN mutants destabilize the destruction complex, activating WNT signaling","5/38","13/2914",3.43126006602394e-07,3.48543785654011e-06,1.81543122606807e-06,"GSK3B/PPP2CB/PPP2CA/AMER1/PPP2R1B",5
"R-HSA-4839744","R-HSA-4839744","truncated APC mutants destabilize the destruction complex","5/38","13/2914",3.43126006602394e-07,3.48543785654011e-06,1.81543122606807e-06,"GSK3B/PPP2CB/PPP2CA/AMER1/PPP2R1B",5
"R-HSA-4839748","R-HSA-4839748","AMER1 mutants destabilize the destruction complex","5/38","13/2914",3.43126006602394e-07,3.48543785654011e-06,1.81543122606807e-06,"GSK3B/PPP2CB/PPP2CA/AMER1/PPP2R1B",5
"R-HSA-5467337","R-HSA-5467337","APC truncation mutants have impaired AXIN binding","5/38","13/2914",3.43126006602394e-07,3.48543785654011e-06,1.81543122606807e-06,"GSK3B/PPP2CB/PPP2CA/AMER1/PPP2R1B",5
"R-HSA-5467340","R-HSA-5467340","AXIN missense mutants destabilize the destruction complex","5/38","13/2914",3.43126006602394e-07,3.48543785654011e-06,1.81543122606807e-06,"GSK3B/PPP2CB/PPP2CA/AMER1/PPP2R1B",5
"R-HSA-5467348","R-HSA-5467348","Truncations of AMER1 destabilize the destruction complex","5/38","13/2914",3.43126006602394e-07,3.48543785654011e-06,1.81543122606807e-06,"GSK3B/PPP2CB/PPP2CA/AMER1/PPP2R1B",5
"R-HSA-166016","R-HSA-166016","Toll Like Receptor 4 (TLR4) Cascade","10/38","110/2914",7.59311166196644e-07,7.51523359363858e-06,3.91439764490038e-06,"MAPK3/MAPK14/RPS6KA3/MAPK11/PPP2CB/PPP2CA/MAPK1/RPS6KA5/PPP2R1B/MAPKAPK2",10
"R-HSA-4641262","R-HSA-4641262","Disassembly of the destruction complex and recruitment of AXIN to the membrane","6/38","30/2914",1.54304929101099e-06,1.48904256582561e-05,7.75585301534474e-06,"CTNNB1/GSK3B/PPP2CB/PPP2CA/AMER1/PPP2R1B",6
"R-HSA-4791275","R-HSA-4791275","Signaling by WNT in cancer","6/38","31/2914",1.8952921527276e-06,1.78434822183623e-05,9.293987193093e-06,"CTNNB1/GSK3B/PPP2CB/PPP2CA/AMER1/PPP2R1B",6
"R-HSA-168898","R-HSA-168898","Toll-like Receptor Cascades","10/38","127/2914",2.90389954457355e-06,2.66882196239379e-05,1.39008725066052e-05,"MAPK3/MAPK14/RPS6KA3/MAPK11/PPP2CB/PPP2CA/MAPK1/RPS6KA5/PPP2R1B/MAPKAPK2",10
"R-HSA-5675221","R-HSA-5675221","Negative regulation of MAPK pathway","6/38","34/2914",3.36469477291133e-06,3.02040042405529e-05,1.57321101989245e-05,"MAPK3/DUSP8/PPP2CB/PPP2CA/MAPK1/PPP2R1B",6
"R-HSA-450341","R-HSA-450341","Activation of the AP-1 family of transcription factors","4/38","10/2914",4.88705690349538e-06,4.28728173806641e-05,2.23308102528138e-05,"MAPK3/MAPK14/MAPK11/MAPK1",4
"R-HSA-195253","R-HSA-195253","Degradation of beta-catenin by the destruction complex","6/38","37/2914",5.65269465101222e-06,4.84875585620159e-05,2.52553141132943e-05,"CTNNB1/GSK3B/PPP2CB/PPP2CA/AMER1/PPP2R1B",6
"R-HSA-201681","R-HSA-201681","TCF dependent signaling in response to WNT","9/38","108/2914",6.26729800328484e-06,5.25908049840858e-05,2.73925381836934e-05,"CTNNB1/GSK3B/MEN1/CSNK2A1/SOX6/PPP2CB/PPP2CA/AMER1/PPP2R1B",9
"R-HSA-69278","R-HSA-69278","Cell Cycle, Mitotic","11/38","191/2914",1.8124653183893e-05,0.000148853534659207,7.75321110442009e-05,"MAPK3/GSK3B/MAX/CSNK2A1/E2F4/PPP2CB/PPP2CA/PPP2R2A/MAPK1/PRKACA/PPP2R1B",11
"R-HSA-1295596","R-HSA-1295596","Spry regulation of FGF signaling","4/38","14/2914",2.24368543844129e-05,0.000180429704007987,9.39789295487472e-05,"MAPK3/PPP2CB/PPP2CA/MAPK1",4
"R-HSA-195258","R-HSA-195258","RHO GTPase Effectors","9/38","130/2914",2.87891420870016e-05,0.000226787935624135,0.000118125158724324,"MAPK3/CTNNB1/MEN1/MAPK14/MAPK11/PPP2CB/PPP2CA/MAPK1/PPP2R1B",9
"R-HSA-432142","R-HSA-432142","Platelet sensitization by LDL","4/38","15/2914",3.03100526357034e-05,0.00023399360634763,0.000121878316914091,"MAPK14/PPP2CB/PPP2CA/PPP2R1B",4
"R-HSA-5668599","R-HSA-5668599","RHO GTPases Activate NADPH Oxidases","4/38","16/2914",4.00361275710029e-05,0.000303018534164845,0.000157830760909423,"MAPK3/MAPK14/MAPK11/MAPK1",4
"R-HSA-1640170","R-HSA-1640170","Cell Cycle","12/38","249/2914",4.20199960595675e-05,0.000311917663057558,0.000162465976667558,"MAPK3/GSK3B/MAX/CSNK2A1/E2F4/PPP2CB/UBE2I/PPP2CA/PPP2R2A/MAPK1/PRKACA/PPP2R1B",12
"R-HSA-68886","R-HSA-68886","M Phase","8/38","105/2914",4.33089149397595e-05,0.000315419644655607,0.000164290024895612,"MAPK3/CSNK2A1/PPP2CB/PPP2CA/PPP2R2A/MAPK1/PRKACA/PPP2R1B",8
"R-HSA-3371453","R-HSA-3371453","Regulation of HSF1-mediated heat shock response","5/38","32/2914",4.48215081430038e-05,0.00032039078042962,0.000166879299323854,"MAPK3/GSK3B/SIRT1/MAPK1/MAPKAPK2",5
"R-HSA-373760","R-HSA-373760","L1CAM interactions","6/38","53/2914",4.79412818930675e-05,0.000336460632922256,0.00017524947065217,"MAPK3/CSNK2A1/RPS6KA3/MAPK1/RPS6KA5/RPS6KA4",6
"R-HSA-187687","R-HSA-187687","Signalling to ERKs","5/38","33/2914",5.23258170259525e-05,0.000354346760912591,0.00018456567039625,"MAPK3/MAPK14/MAPK11/MAPK1/MAPKAPK2",5
"R-HSA-68875","R-HSA-68875","Mitotic Prophase","5/38","33/2914",5.23258170259525e-05,0.000354346760912591,0.00018456567039625,"MAPK3/PPP2CB/PPP2CA/MAPK1/PPP2R1B",5
"R-HSA-69273","R-HSA-69273","Cyclin A/B1/B2 associated events during G2/M transition","4/38","18/2914",6.60627833997511e-05,0.000439659213660412,0.000229001662964654,"PPP2CB/PPP2CA/PPP2R2A/PPP2R1B",4
"R-HSA-437239","R-HSA-437239","Recycling pathway of L1","4/38","20/2914",0.000102656394908673,0.000649596203848322,0.000338349808931087,"RPS6KA3/MAPK1/RPS6KA5/RPS6KA4",4
"R-HSA-70171","R-HSA-70171","Glycolysis","4/38","20/2914",0.000102656394908673,0.000649596203848322,0.000338349808931087,"PPP2CB/PPP2CA/PRKACA/PPP2R1B",4
"R-HSA-70326","R-HSA-70326","Glucose metabolism","4/38","20/2914",0.000102656394908673,0.000649596203848322,0.000338349808931087,"PPP2CB/PPP2CA/PRKACA/PPP2R1B",4
"R-HSA-69231","R-HSA-69231","Cyclin D associated events in G1","5/38","40/2914",0.000135737328980434,0.000831660460102344,0.000433180114206566,"E2F4/PPP2CB/PPP2CA/PPP2R2A/PPP2R1B",5
"R-HSA-69236","R-HSA-69236","G1 Phase","5/38","40/2914",0.000135737328980434,0.000831660460102344,0.000433180114206566,"E2F4/PPP2CB/PPP2CA/PPP2R2A/PPP2R1B",5
"R-HSA-180024","R-HSA-180024","DARPP-32 events","4/38","22/2914",0.00015211267580925,0.000917429575974536,0.000477853965124452,"PPP2CB/PPP2CA/PRKACA/PPP2R1B",4
"R-HSA-449147","R-HSA-449147","Signaling by Interleukins","13/38","332/2914",0.000163650431227228,0.000971831791595539,0.000506189997804058,"MAPK3/MAPK14/SMAD3/RPS6KA3/TGFB1/MAPK11/PPP2CB/PPP2CA/MAPK1/RPS6KA5/PRKACA/PPP2R1B/MAPKAPK2",13
"R-HSA-2559580","R-HSA-2559580","Oxidative Stress Induced Senescence","5/38","44/2914",0.000215673274025499,0.00123100617451247,0.000641184017812602,"MAPK3/MAPK14/MAPK11/MAPK1/MAPKAPK2",5
"R-HSA-71387","R-HSA-71387","Metabolism of carbohydrates","5/38","44/2914",0.000215673274025499,0.00123100617451247,0.000641184017812602,"PPP2CB/PPP2CA/FMOD/PRKACA/PPP2R1B",5
"R-HSA-2173796","R-HSA-2173796","SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription","4/38","24/2914",0.000216861191364891,0.00123100617451247,0.000641184017812602,"MEN1/SMAD3/E2F4/SMAD2",4
"R-HSA-113501","R-HSA-113501","Inhibition of replication initiation of damaged DNA by RB1/E2F1","3/38","10/2914",0.000230641451834496,0.00129025507837848,0.000672044504963977,"PPP2CB/PPP2CA/PPP2R1B",3
"R-HSA-195721","R-HSA-195721","Signaling by WNT","9/38","172/2914",0.000259680461493564,0.00143195225909308,0.000745849145041666,"CTNNB1/GSK3B/MEN1/CSNK2A1/SOX6/PPP2CB/PPP2CA/AMER1/PPP2R1B",9
"R-HSA-113510","R-HSA-113510","E2F mediated regulation of DNA replication","3/38","11/2914",0.000314279024026778,0.00170861553907516,0.000889952462403479,"PPP2CB/PPP2CA/PPP2R1B",3
"R-HSA-5617472","R-HSA-5617472","Activation of anterior HOX genes in hindbrain development during early embryogenesis","4/38","27/2914",0.000348244777763679,0.00181652005698351,0.000946155797338018,"RARA/PCGF2/YY1/PAX6",4
"R-HSA-5619507","R-HSA-5619507","Activation of HOX genes during differentiation","4/38","27/2914",0.000348244777763679,0.00181652005698351,0.000946155797338018,"RARA/PCGF2/YY1/PAX6",4
"R-HSA-5654732","R-HSA-5654732","Negative regulation of FGFR3 signaling","4/38","27/2914",0.000348244777763679,0.00181652005698351,0.000946155797338018,"MAPK3/PPP2CB/PPP2CA/MAPK1",4
"R-HSA-3371556","R-HSA-3371556","Cellular response to heat stress","5/38","49/2914",0.000361124938868406,0.00185858968537606,0.000968068257177061,"MAPK3/GSK3B/SIRT1/MAPK1/MAPKAPK2",5
"R-HSA-453279","R-HSA-453279","Mitotic G1-G1/S phases","6/38","77/2914",0.000393933924000945,0.00200076966663638,0.00104212436958699,"MAX/E2F4/PPP2CB/PPP2CA/PPP2R2A/PPP2R1B",6
"R-HSA-5654733","R-HSA-5654733","Negative regulation of FGFR4 signaling","4/38","28/2914",0.000402498550440481,0.00201772000610423,0.00105095315289312,"MAPK3/PPP2CB/PPP2CA/MAPK1",4
"R-HSA-5663202","R-HSA-5663202","Diseases of signal transduction","11/38","268/2914",0.000408322860943712,0.00202067467082401,0.00105249212469972,"MAPK3/CTNNB1/GSK3B/SMAD3/TGFB1/PPP2CB/SMAD2/PPP2CA/MAPK1/AMER1/PPP2R1B",11
"R-HSA-5654726","R-HSA-5654726","Negative regulation of FGFR1 signaling","4/38","30/2914",0.000528734599657592,0.00258136596902313,0.00134453476979388,"MAPK3/PPP2CB/PPP2CA/MAPK1",4
"R-HSA-171007","R-HSA-171007","p38MAPK events","3/38","13/2914",0.000534998128294949,0.00258136596902313,0.00134453476979388,"MAPK14/MAPK11/MAPKAPK2",3
"R-HSA-68877","R-HSA-68877","Mitotic Prometaphase","5/38","56/2914",0.000676855641020426,0.00320531596066102,0.00166952644801269,"CSNK2A1/PPP2CB/PPP2CA/PRKACA/PPP2R1B",5
"R-HSA-5654727","R-HSA-5654727","Negative regulation of FGFR2 signaling","4/38","32/2914",0.000680922043456486,0.00320531596066102,0.00166952644801269,"MAPK3/PPP2CB/PPP2CA/MAPK1",4
"R-HSA-9006936","R-HSA-9006936","Signaling by TGF-beta family members","6/38","86/2914",0.000716923592204775,0.00333412658543425,0.00173661897414219,"MEN1/SMAD3/SMAD1/TGFB1/E2F4/SMAD2",6
"R-HSA-1181150","R-HSA-1181150","Signaling by NODAL","3/38","15/2914",0.000835906945133806,0.00384119143835296,0.00200072965564608,"SMAD3/SMAD2/TDGF1",3
"R-HSA-111885","R-HSA-111885","Opioid Signalling","5/38","59/2914",0.000862188363983326,0.00391534951173604,0.00203935575877171,"PPP2CB/PPP2CA/MAPK1/PRKACA/PPP2R1B",5
"R-HSA-69206","R-HSA-69206","G1/S Transition","5/38","60/2914",0.000931677576559303,0.00418171563432431,0.00217809568081795,"MAX/E2F4/PPP2CB/PPP2CA/PPP2R1B",5
"R-HSA-9006934","R-HSA-9006934","Signaling by Receptor Tyrosine Kinases","12/38","347/2914",0.00101163077134992,0.00448838480162149,0.00233782791685221,"MAPK3/CTNNB1/MAPK14/RPS6KA3/MAPK11/PPP2CB/PPP2CA/MAPK1/RPS6KA5/PRKACA/PPP2R1B/MAPKAPK2",12
"R-HSA-2173793","R-HSA-2173793","Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer","4/38","36/2914",0.00107442580305701,0.00471282227250009,0.00245472880841973,"MEN1/SMAD3/E2F4/SMAD2",4
"R-HSA-422475","R-HSA-422475","Axon guidance","10/38","254/2914",0.00111396256194514,0.00483134324618905,0.00251646184898311,"MAPK3/GSK3B/MAPK14/CSNK2A1/RPS6KA3/MAPK11/MAPK1/RPS6KA5/PRKACA/RPS6KA4",10
"R-HSA-170834","R-HSA-170834","Signaling by TGF-beta Receptor Complex","5/38","63/2914",0.00116536568674794,0.00499812394538559,0.00260333153413866,"MEN1/SMAD3/TGFB1/E2F4/SMAD2",5
"R-HSA-5654741","R-HSA-5654741","Signaling by FGFR3","4/38","37/2914",0.00119344481030118,0.00506230436017865,0.00263676065665155,"MAPK3/PPP2CB/PPP2CA/MAPK1",4
"R-HSA-5633007","R-HSA-5633007","Regulation of TP53 Activity","6/38","95/2914",0.00121622721172974,0.00510286634486607,0.00265788784256727,"MAPK14/CSNK2A1/MAPK11/PPP2CB/PPP2CA/PPP2R1B",6
"R-HSA-5654743","R-HSA-5654743","Signaling by FGFR4","4/38","38/2914",0.00132143483658491,0.00548466502066425,0.00285675216511282,"MAPK3/PPP2CB/PPP2CA/MAPK1",4
"R-HSA-69275","R-HSA-69275","G2/M Transition","5/38","66/2914",0.00144010042551196,0.00591360387497465,0.0030801700030547,"PPP2CB/PPP2CA/PPP2R2A/PRKACA/PPP2R1B",5
"R-HSA-881907","R-HSA-881907","Gastrin-CREB signalling pathway via PKC and MAPK","3/38","18/2914",0.00145910873919705,0.00592858919294802,0.00308797528184639,"MAPK3/RPS6KA3/MAPK1",3
"R-HSA-2559583","R-HSA-2559583","Cellular Senescence","6/38","99/2914",0.00150933280610321,0.00606877565787331,0.00316099304786965,"MAPK3/MAPK14/RPS6KA3/MAPK11/MAPK1/MAPKAPK2",6
"R-HSA-453274","R-HSA-453274","Mitotic G2-G2/M phases","5/38","68/2914",0.00164814638783057,0.00655860315157319,0.00341612544846054,"PPP2CB/PPP2CA/PPP2R2A/PRKACA/PPP2R1B",5
"R-HSA-389513","R-HSA-389513","CTLA4 inhibitory signaling","3/38","19/2914",0.00171714813488525,0.00676346102107862,0.00352282807479143,"PPP2CB/PPP2CA/PPP2R1B",3
"R-HSA-5654736","R-HSA-5654736","Signaling by FGFR1","4/38","41/2914",0.00176279504427743,0.00687312007162715,0.00357994527864954,"MAPK3/PPP2CB/PPP2CA/MAPK1",4
"R-HSA-418346","R-HSA-418346","Platelet homeostasis","4/38","42/2914",0.0019302284971489,0.00745068199899473,0.00388077518900462,"MAPK14/PPP2CB/PPP2CA/PPP2R1B",4
"R-HSA-167044","R-HSA-167044","Signalling to RAS","3/38","20/2914",0.00200205844193994,0.00757641724106682,0.00394626586594972,"MAPK14/MAPK11/MAPKAPK2",3
"R-HSA-445144","R-HSA-445144","Signal transduction by L1","3/38","20/2914",0.00200205844193994,0.00757641724106682,0.00394626586594972,"MAPK3/CSNK2A1/MAPK1",3
"R-HSA-194315","R-HSA-194315","Signaling by Rho GTPases","9/38","228/2914",0.00204572930148309,0.00766651951817935,0.00399319669477026,"MAPK3/CTNNB1/MEN1/MAPK14/MAPK11/PPP2CB/PPP2CA/MAPK1/PPP2R1B",9
"R-HSA-2262752","R-HSA-2262752","Cellular responses to stress","8/38","187/2914",0.00228133073662167,0.0084672467724612,0.00441026488557428,"MAPK3/GSK3B/MAPK14/SIRT1/RPS6KA3/MAPK11/MAPK1/MAPKAPK2",8
"R-HSA-450302","R-HSA-450302","activated TAK1 mediates p38 MAPK activation","3/38","21/2914",0.00231479689232363,0.00850963428987543,0.00443234292164223,"MAPK14/MAPK11/MAPKAPK2",3
"R-HSA-8953897","R-HSA-8953897","Cellular responses to external stimuli","8/38","189/2914",0.00244118546536275,0.00888959990217002,0.00463025247154206,"MAPK3/GSK3B/MAPK14/SIRT1/RPS6KA3/MAPK11/MAPK1/MAPKAPK2",8
"R-HSA-2173788","R-HSA-2173788","Downregulation of TGF-beta receptor signaling","3/38","22/2914",0.00265627334756274,0.0094066193776075,0.00489954813505054,"SMAD3/TGFB1/SMAD2",3
"R-HSA-442742","R-HSA-442742","CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling","3/38","22/2914",0.00265627334756274,0.0094066193776075,0.00489954813505054,"MAPK3/RPS6KA3/MAPK1",3
"R-HSA-525793","R-HSA-525793","Myogenesis","3/38","22/2914",0.00265627334756274,0.0094066193776075,0.00489954813505054,"CTNNB1/MAPK14/MAPK11",3
"R-HSA-1643685","R-HSA-1643685","Disease","13/38","443/2914",0.00274506319170885,0.00963267629090562,0.00501729253221427,"MAPK3/CTNNB1/GSK3B/SMAD3/TGFB1/PPP2CB/SMAD2/PPP2CA/MAPK1/AMER1/FMOD/PRKACA/PPP2R1B",13
"R-HSA-438064","R-HSA-438064","Post NMDA receptor activation events","4/38","47/2914",0.0029355366140545,0.010208262459685,0.00531709334551361,"MAPK3/RPS6KA3/MAPK1/PRKACA",4
"R-HSA-112409","R-HSA-112409","RAF-independent MAPK1/3 activation","3/38","23/2914",0.00302735151349634,0.0104335507518713,0.00543443739734774,"MAPK3/DUSP8/MAPK1",3
"R-HSA-442755","R-HSA-442755","Activation of NMDA receptors and postsynaptic events","4/38","49/2914",0.0034225552736562,0.0116099662328444,0.00604718721154426,"MAPK3/RPS6KA3/MAPK1/PRKACA",4
"R-HSA-8941326","R-HSA-8941326","RUNX2 regulates bone development","3/38","24/2914",0.00342885013094368,0.0116099662328444,0.00604718721154426,"MAPK3/SMAD1/MAPK1",3
"R-HSA-9006925","R-HSA-9006925","Intracellular signaling by second messengers","8/38","201/2914",0.00359611240701428,0.0120704294705001,0.00628702489464282,"MAPK3/GSK3B/CSNK2A1/PPP2CB/PPP2CA/MAPK1/PRKACA/PPP2R1B",8
"R-HSA-5654738","R-HSA-5654738","Signaling by FGFR2","4/38","50/2914",0.00368560738012207,0.0122641762821303,0.00638794019603734,"MAPK3/PPP2CB/PPP2CA/MAPK1",4
"R-HSA-4420097","R-HSA-4420097","VEGFA-VEGFR2 Pathway","5/38","85/2914",0.00441328738480691,0.014560076329363,0.00758378668914189,"CTNNB1/MAPK14/MAPK11/PRKACA/MAPKAPK2",5
"R-HSA-163685","R-HSA-163685","Integration of energy metabolism","4/38","55/2914",0.00520933096816843,0.0168974937286808,0.00880125798248713,"PPP2CB/PPP2CA/PRKACA/PPP2R1B",4
"R-HSA-190236","R-HSA-190236","Signaling by FGFR","4/38","55/2914",0.00520933096816843,0.0168974937286808,0.00880125798248713,"MAPK3/PPP2CB/PPP2CA/MAPK1",4
"R-HSA-2173789","R-HSA-2173789","TGF-beta receptor signaling activates SMADs","3/38","28/2914",0.00535391486001618,0.0172217594663854,0.00897015559879905,"SMAD3/TGFB1/SMAD2",3
"R-HSA-1257604","R-HSA-1257604","PIP3 activates AKT signaling","7/38","172/2914",0.00586738482800971,0.0181306757079292,0.00944357529374007,"MAPK3/GSK3B/CSNK2A1/PPP2CB/PPP2CA/MAPK1/PPP2R1B",7
"R-HSA-141424","R-HSA-141424","Amplification of signal from the kinetochores","3/38","29/2914",0.00591830346942768,0.0181306757079292,0.00944357529374007,"PPP2CB/PPP2CA/PPP2R1B",3
"R-HSA-141444","R-HSA-141444","Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal","3/38","29/2914",0.00591830346942768,0.0181306757079292,0.00944357529374007,"PPP2CB/PPP2CA/PPP2R1B",3
"R-HSA-5673000","R-HSA-5673000","RAF activation","3/38","29/2914",0.00591830346942768,0.0181306757079292,0.00944357529374007,"PPP2CB/PPP2CA/PPP2R1B",3
"R-HSA-6804757","R-HSA-6804757","Regulation of TP53 Degradation","3/38","29/2914",0.00591830346942768,0.0181306757079292,0.00944357529374007,"PPP2CB/PPP2CA/PPP2R1B",3
"R-HSA-6806003","R-HSA-6806003","Regulation of TP53 Expression and Degradation","3/38","29/2914",0.00591830346942768,0.0181306757079292,0.00944357529374007,"PPP2CB/PPP2CA/PPP2R1B",3
"R-HSA-194138","R-HSA-194138","Signaling by VEGF","5/38","92/2914",0.00619137810642926,0.018532997991875,0.00965312957853322,"CTNNB1/MAPK14/MAPK11/PRKACA/MAPKAPK2",5
"R-HSA-6811558","R-HSA-6811558","PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling","5/38","92/2914",0.00619137810642926,0.018532997991875,0.00965312957853322,"MAPK3/PPP2CB/PPP2CA/MAPK1/PPP2R1B",5
"R-HSA-168249","R-HSA-168249","Innate Immune System","12/38","428/2914",0.00619367031334684,0.018532997991875,0.00965312957853322,"MAPK3/CTNNB1/MAPK14/RPS6KA3/MAPK11/PPP2CB/PPP2CA/MAPK1/RPS6KA5/PRKACA/PPP2R1B/MAPKAPK2",12
"R-HSA-111458","R-HSA-111458","Formation of apoptosome","2/38","10/2914",0.00697740560867865,0.0204036254920452,0.0106274678728678,"MAPK3/MAPK1",2
"R-HSA-74749","R-HSA-74749","Signal attenuation","2/38","10/2914",0.00697740560867865,0.0204036254920452,0.0106274678728678,"MAPK3/MAPK1",2
"R-HSA-9627069","R-HSA-9627069","Regulation of the apoptosome activity","2/38","10/2914",0.00697740560867865,0.0204036254920452,0.0106274678728678,"MAPK3/MAPK1",2
"R-HSA-68882","R-HSA-68882","Mitotic Anaphase","4/38","60/2914",0.00710906419452681,0.0204464863423777,0.0106497924499431,"PPP2CB/PPP2CA/PPP2R2A/PPP2R1B",4
"R-HSA-3769402","R-HSA-3769402","Deactivation of the beta-catenin transactivating complex","3/38","31/2914",0.00715097320264506,0.0204464863423777,0.0106497924499431,"CTNNB1/MEN1/SOX6",3
"R-HSA-450531","R-HSA-450531","Regulation of mRNA stability by proteins that bind AU-rich elements","3/38","31/2914",0.00715097320264506,0.0204464863423777,0.0106497924499431,"MAPK14/MAPK11/MAPKAPK2",3
"R-HSA-2555396","R-HSA-2555396","Mitotic Metaphase and Anaphase","4/38","61/2914",0.00753740066934623,0.0213929166056444,0.0111427517635072,"PPP2CB/PPP2CA/PPP2R2A/PPP2R1B",4
"R-HSA-375165","R-HSA-375165","NCAM signaling for neurite out-growth","3/38","32/2914",0.00782028883980249,0.0220338065121443,0.0114765667952538,"MAPK3/MAPK1/RPS6KA5",3
"R-HSA-8878166","R-HSA-8878166","Transcriptional regulation by RUNX2","4/38","62/2914",0.00798252384201065,0.0223279290073631,0.0116297639498401,"MAPK3/GSK3B/SMAD1/MAPK1",4
"R-HSA-199418","R-HSA-199418","Negative regulation of the PI3K/AKT network","5/38","99/2914",0.00842631758278772,0.0231547996910173,0.0120604492527524,"MAPK3/PPP2CB/PPP2CA/MAPK1/PPP2R1B",5
"R-HSA-1362277","R-HSA-1362277","Transcription of E2F targets under negative control by DREAM complex","2/38","11/2914",0.00845810040526796,0.0231547996910173,0.0120604492527524,"MAX/E2F4",2
"R-HSA-452723","R-HSA-452723","Transcriptional regulation of pluripotent stem cells","2/38","11/2914",0.00845810040526796,0.0231547996910173,0.0120604492527524,"SMAD2/TDGF1",2
"R-HSA-597592","R-HSA-597592","Post-translational protein modification","11/38","393/2914",0.00924920313078214,0.0250149646441244,0.0130293380066206,"MEN1/RARA/SMAD3/SMAD1/TGFB1/PCGF2/UBE2I/FBXO22/LTBP1/YY1/SMAD2",11
"R-HSA-2500257","R-HSA-2500257","Resolution of Sister Chromatid Cohesion","3/38","34/2914",0.00926720192774556,0.0250149646441244,0.0130293380066206,"PPP2CB/PPP2CA/PPP2R1B",3
"R-HSA-111461","R-HSA-111461","Cytochrome c-mediated apoptotic response","2/38","12/2914",0.0100666664335159,0.0264335594784838,0.0137682297801756,"MAPK3/MAPK1",2
"R-HSA-1502540","R-HSA-1502540","Signaling by Activin","2/38","12/2914",0.0100666664335159,0.0264335594784838,0.0137682297801756,"SMAD3/SMAD2",2
"R-HSA-170968","R-HSA-170968","Frs2-mediated activation","2/38","12/2914",0.0100666664335159,0.0264335594784838,0.0137682297801756,"MAPK3/MAPK1",2
"R-HSA-381771","R-HSA-381771","Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)","2/38","12/2914",0.0100666664335159,0.0264335594784838,0.0137682297801756,"CTNNB1/PAX6",2
"R-HSA-3700989","R-HSA-3700989","Transcriptional Regulation by TP53","7/38","194/2914",0.011195009105795,0.029197794019168,0.0152080137923673,"MAPK14/CSNK2A1/MAPK11/E2F4/PPP2CB/PPP2CA/PPP2R1B",7
"R-HSA-169893","R-HSA-169893","Prolonged ERK activation events","2/38","13/2914",0.0117996970344651,0.0303645537020236,0.0158157342707568,"MAPK3/MAPK1",2
"R-HSA-5626467","R-HSA-5626467","RHO GTPases activate IQGAPs","2/38","13/2914",0.0117996970344651,0.0303645537020236,0.0158157342707568,"CTNNB1/MEN1",2
"R-HSA-8953854","R-HSA-8953854","Metabolism of RNA","5/38","109/2914",0.0125190554445129,0.0320023536528609,0.0166688016026627,"MAPK14/MAPK11/PPP2CA/PPP2R2A/MAPKAPK2",5
"R-HSA-400508","R-HSA-400508","Incretin synthesis, secretion, and inactivation","2/38","14/2914",0.0136538486124369,0.0340024875122623,0.0177105948045871,"CTNNB1/PAX6",2
"R-HSA-927802","R-HSA-927802","Nonsense-Mediated Decay (NMD)","2/38","14/2914",0.0136538486124369,0.0340024875122623,0.0177105948045871,"PPP2CA/PPP2R2A",2
"R-HSA-9617828","R-HSA-9617828","FOXO-mediated transcription of cell cycle genes","2/38","14/2914",0.0136538486124369,0.0340024875122623,0.0177105948045871,"SMAD3/SMAD2",2
"R-HSA-975957","R-HSA-975957","Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)","2/38","14/2914",0.0136538486124369,0.0340024875122623,0.0177105948045871,"PPP2CA/PPP2R2A",2
"R-HSA-5683057","R-HSA-5683057","MAPK family signaling cascades","7/38","202/2914",0.0138187554409177,0.0341925615397067,0.0178095970932206,"MAPK3/DUSP8/PPP2CB/PPP2CA/MAPK1/PRKACA/PPP2R1B",7
"R-HSA-69618","R-HSA-69618","Mitotic Spindle Checkpoint","3/38","42/2914",0.0165510327817402,0.0406923481130683,0.0211950872364223,"PPP2CB/PPP2CA/PPP2R1B",3
"R-HSA-112314","R-HSA-112314","Neurotransmitter receptors and postsynaptic signal transmission","4/38","77/2914",0.0168433855880567,0.04114903061386,0.02143295567834,"MAPK3/RPS6KA3/MAPK1/PRKACA",4
"R-HSA-111471","R-HSA-111471","Apoptotic factor-mediated response","2/38","16/2914",0.0177124496662732,0.0430000350388772,0.0223970730636093,"MAPK3/MAPK1",2
"R-HSA-4570464","R-HSA-4570464","SUMOylation of RNA binding proteins","2/38","17/2914",0.0199105183666789,0.0477530032078765,0.0248727123335271,"PCGF2/UBE2I",2
"R-HSA-2559582","R-HSA-2559582","Senescence-Associated Secretory Phenotype (SASP)","3/38","45/2914",0.0199177034105391,0.0477530032078765,0.0248727123335271,"MAPK3/RPS6KA3/MAPK1",3
"R-HSA-5688426","R-HSA-5688426","Deubiquitination","5/38","124/2914",0.0209315893555287,0.0498740338965066,0.025977476068265,"SMAD3/SMAD1/TGFB1/YY1/SMAD2",5
"R-HSA-5673001","R-HSA-5673001","RAF/MAP kinase cascade","6/38","171/2914",0.0215132974973951,0.0509456002085554,0.0265356139619146,"MAPK3/DUSP8/PPP2CB/PPP2CA/MAPK1/PPP2R1B",6
"R-HSA-5610783","R-HSA-5610783","Degradation of GLI2 by the proteasome","2/38","18/2914",0.0222169445701141,0.0519741854791761,0.0270713646755458,"GSK3B/PRKACA",2
"R-HSA-8953750","R-HSA-8953750","Transcriptional Regulation by E2F6","2/38","18/2914",0.0222169445701141,0.0519741854791761,0.0270713646755458,"MAX/PCGF2",2
"R-HSA-5663220","R-HSA-5663220","RHO GTPases Activate Formins","3/38","47/2914",0.0223579035396979,0.0519888600380926,0.0270790080918344,"PPP2CB/PPP2CA/PPP2R1B",3
"R-HSA-1538133","R-HSA-1538133","G0 and Early G1","2/38","19/2914",0.0246286853271999,0.0555945762356676,0.0289570877038792,"MAX/E2F4",2
"R-HSA-5610785","R-HSA-5610785","GLI3 is processed to GLI3R by the proteasome","2/38","19/2914",0.0246286853271999,0.0555945762356676,0.0289570877038792,"GSK3B/PRKACA",2
"R-HSA-5621575","R-HSA-5621575","CD209 (DC-SIGN) signaling","2/38","19/2914",0.0246286853271999,0.0555945762356676,0.0289570877038792,"RPS6KA5/PRKACA",2
"R-HSA-8940973","R-HSA-8940973","RUNX2 regulates osteoblast differentiation","2/38","19/2914",0.0246286853271999,0.0555945762356676,0.0289570877038792,"MAPK3/MAPK1",2
"R-HSA-9615017","R-HSA-9615017","FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes","2/38","19/2914",0.0246286853271999,0.0555945762356676,0.0289570877038792,"SMAD3/SMAD2",2
"R-HSA-9614085","R-HSA-9614085","FOXO-mediated transcription","3/38","49/2914",0.0249552491315052,0.0559140822263561,0.0291235061500791,"SIRT1/SMAD3/SMAD2",3
"R-HSA-5684996","R-HSA-5684996","MAPK1/MAPK3 signaling","6/38","177/2914",0.0250599384071492,0.0559140822263561,0.0291235061500791,"MAPK3/DUSP8/PPP2CB/PPP2CA/MAPK1/PPP2R1B",6
"R-HSA-112315","R-HSA-112315","Transmission across Chemical Synapses","4/38","88/2914",0.0262084768112771,0.0581406439606493,0.0302832369688683,"MAPK3/RPS6KA3/MAPK1/PRKACA",4
"R-HSA-2173795","R-HSA-2173795","Downregulation of SMAD2/3:SMAD4 transcriptional activity","2/38","20/2914",0.0271427549811177,0.0598691624154938,0.0311835560986074,"SMAD3/SMAD2",2
"R-HSA-1430728","R-HSA-1430728","Metabolism","8/38","289/2914",0.0295403179020656,0.0647872881261212,0.0337452196130056,"CSNK2A1/PPP2CB/UBE2I/PPP2CA/FMOD/PRKACA/PPP2R1B/MAPKAPK2",8
"R-HSA-388841","R-HSA-388841","Costimulation by the CD28 family","3/38","53/2914",0.0306213197051185,0.0664035359897514,0.0345870612872717,"PPP2CB/PPP2CA/PPP2R1B",3
"R-HSA-8878159","R-HSA-8878159","Transcriptional regulation by RUNX3","3/38","53/2914",0.0306213197051185,0.0664035359897514,0.0345870612872717,"CTNNB1/SMAD3/TGFB1",3
"R-HSA-201722","R-HSA-201722","Formation of the beta-catenin:TCF transactivating complex","2/38","22/2914",0.0324662193442282,0.0698134074606499,0.0363631328742409,"CTNNB1/MEN1",2
"R-HSA-9607240","R-HSA-9607240","FLT3 Signaling","6/38","188/2914",0.0325554749816502,0.0698134074606499,0.0363631328742409,"MAPK3/DUSP8/PPP2CB/PPP2CA/MAPK1/PPP2R1B",6
"R-HSA-109582","R-HSA-109582","Hemostasis","8/38","298/2914",0.0347256073729881,0.0736144736560676,0.0383429628260401,"MAPK3/MAPK14/TGFB1/PPP2CB/PPP2CA/MAPK1/PRKACA/PPP2R1B",8
"R-HSA-2559585","R-HSA-2559585","Oncogene Induced Senescence","2/38","23/2914",0.0352699210423932,0.0736144736560676,0.0383429628260401,"MAPK3/MAPK1",2
"R-HSA-4551638","R-HSA-4551638","SUMOylation of chromatin organization proteins","2/38","23/2914",0.0352699210423932,0.0736144736560676,0.0383429628260401,"PCGF2/UBE2I",2
"R-HSA-2467813","R-HSA-2467813","Separation of Sister Chromatids","3/38","56/2914",0.0352815482548511,0.0736144736560676,0.0383429628260401,"PPP2CB/PPP2CA/PPP2R1B",3
"R-HSA-6804756","R-HSA-6804756","Regulation of TP53 Activity through Phosphorylation","3/38","56/2914",0.0352815482548511,0.0736144736560676,0.0383429628260401,"MAPK14/CSNK2A1/MAPK11",3
"R-HSA-9634638","R-HSA-9634638","Estrogen-dependent nuclear events downstream of ESR-membrane signaling","2/38","24/2914",0.0381645638525249,0.0787781906260675,0.0410325454310851,"MAPK3/MAPK1",2
"R-HSA-982772","R-HSA-982772","Growth hormone receptor signaling","2/38","24/2914",0.0381645638525249,0.0787781906260675,0.0410325454310851,"MAPK3/MAPK1",2
"R-HSA-6807070","R-HSA-6807070","PTEN Regulation","3/38","59/2914",0.040290455171038,0.0827234893792349,0.0430875006038556,"MAPK3/CSNK2A1/MAPK1",3
"R-HSA-2129379","R-HSA-2129379","Molecules associated with elastic fibres","2/38","25/2914",0.0411474351316402,0.0827234893792349,0.0430875006038556,"TGFB1/LTBP1",2
"R-HSA-456926","R-HSA-456926","Thrombin signalling through proteinase activated receptors (PARs)","2/38","25/2914",0.0411474351316402,0.0827234893792349,0.0430875006038556,"MAPK3/MAPK1",2
"R-HSA-5663213","R-HSA-5663213","RHO GTPases Activate WASPs and WAVEs","2/38","25/2914",0.0411474351316402,0.0827234893792349,0.0430875006038556,"MAPK3/MAPK1",2
"R-HSA-8864260","R-HSA-8864260","Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors","2/38","25/2914",0.0411474351316402,0.0827234893792349,0.0430875006038556,"UBE2I/YY1",2
"R-HSA-111996","R-HSA-111996","Ca-dependent events","2/38","26/2914",0.0442158742395046,0.0884317484790092,0.046060714370032,"MAPK1/PRKACA",2
"R-HSA-112316","R-HSA-112316","Neuronal System","4/38","105/2914",0.0459115037942837,0.0913496931164614,0.0475805600906576,"MAPK3/RPS6KA3/MAPK1/PRKACA",4
"R-HSA-5689603","R-HSA-5689603","UCH proteinases","2/38","27/2914",0.0473672717010886,0.0937629070595908,0.0488375109036865,"TGFB1/YY1",2
"R-HSA-1566948","R-HSA-1566948","Elastic fibre formation","2/38","28/2914",0.0505990683811711,0.0991433522595536,0.0516399789516628,"TGFB1/LTBP1",2
"R-HSA-4090294","R-HSA-4090294","SUMOylation of intracellular receptors","2/38","28/2914",0.0505990683811711,0.0991433522595536,0.0516399789516628,"RARA/UBE2I",2
"R-HSA-2871796","R-HSA-2871796","FCERI mediated MAPK activation","2/38","30/2914",0.0572938696863565,0.111694109590574,0.0581771882514306,"MAPK3/MAPK1",2
"R-HSA-69242","R-HSA-69242","S Phase","3/38","71/2914",0.0637072635999772,0.123444684398687,0.0642976130901263,"GSK3B/MAX/E2F4",3
"R-HSA-6802948","R-HSA-6802948","Signaling by high-kinase activity BRAF mutants","2/38","32/2914",0.0642807812542388,0.123444684398687,0.0642976130901263,"MAPK3/MAPK1",2
"R-HSA-8943724","R-HSA-8943724","Regulation of PTEN gene transcription","2/38","32/2914",0.0642807812542388,0.123444684398687,0.0642976130901263,"MAPK3/MAPK1",2
"R-HSA-556833","R-HSA-556833","Metabolism of lipids","4/38","119/2914",0.0670404321952334,0.128106964491882,0.0667260164110973,"CSNK2A1/UBE2I/PRKACA/MAPKAPK2",4
"R-HSA-168638","R-HSA-168638","NOD1/2 Signaling Pathway","2/38","33/2914",0.0678778926108569,0.129068308117196,0.0672267435243644,"MAPK14/MAPK11",2
"R-HSA-112040","R-HSA-112040","G-protein mediated events","2/38","34/2914",0.0715410607785513,0.134052667284082,0.0698229055120251,"MAPK1/PRKACA",2
"R-HSA-112043","R-HSA-112043","PLC beta mediated events","2/38","34/2914",0.0715410607785513,0.134052667284082,0.0698229055120251,"MAPK1/PRKACA",2
"R-HSA-5674135","R-HSA-5674135","MAP2K and MAPK activation","2/38","34/2914",0.0715410607785513,0.134052667284082,0.0698229055120251,"MAPK3/MAPK1",2
"R-HSA-373752","R-HSA-373752","Netrin-1 signaling","2/38","35/2914",0.0752680568764405,0.139680144011087,0.0727540428309723,"MAPK14/MAPK11",2
"R-HSA-5610787","R-HSA-5610787","Hedgehog 'off' state","2/38","35/2914",0.0752680568764405,0.139680144011087,0.0727540428309723,"GSK3B/PRKACA",2
"R-HSA-212165","R-HSA-212165","Epigenetic regulation of gene expression","2/38","37/2914",0.0829048373903571,0.152386986822275,0.0793725510855048,"GSK3B/SIRT1",2
"R-HSA-3899300","R-HSA-3899300","SUMOylation of transcription cofactors","2/38","37/2914",0.0829048373903571,0.152386986822275,0.0793725510855048,"PCGF2/UBE2I",2
"R-HSA-1852241","R-HSA-1852241","Organelle biogenesis and maintenance","3/38","80/2914",0.0846098755347563,0.154053829983094,0.0802407459142923,"MAPK14/MAPK11/PRKACA",3
"R-HSA-5689880","R-HSA-5689880","Ub-specific processing proteases","3/38","80/2914",0.0846098755347563,0.154053829983094,0.0802407459142923,"SMAD3/SMAD1/SMAD2",3
"R-HSA-1592230","R-HSA-1592230","Mitochondrial biogenesis","2/38","38/2914",0.0868103819368349,0.15658321227859,0.0815582043774494,"MAPK14/MAPK11",2
"R-HSA-3108214","R-HSA-3108214","SUMOylation of DNA damage response and repair proteins","2/38","38/2914",0.0868103819368349,0.15658321227859,0.0815582043774494,"PCGF2/UBE2I",2
"R-HSA-69202","R-HSA-69202","Cyclin E associated events during G1/S transition ","2/38","39/2914",0.0907712732597672,0.162966099898931,0.084882806328595,"MAX/E2F4",2
"R-HSA-69656","R-HSA-69656","Cyclin A:Cdk2-associated events at S phase entry","2/38","40/2914",0.0947854961262788,0.169385192151591,0.0882262658875207,"MAX/E2F4",2
"R-HSA-9006931","R-HSA-9006931","Signaling by Nuclear Receptors","4/38","136/2914",0.09848896497021,0.175192352435489,0.0912509934965322,"MAPK3/RARA/YY1/MAPK1",4
"R-HSA-2980736","R-HSA-2980736","Peptide hormone metabolism","2/38","42/2914",0.10296607810546,0.179031108777962,0.0932504548039017,"CTNNB1/PAX6",2
"R-HSA-6802946","R-HSA-6802946","Signaling by moderate kinase activity BRAF mutants","2/38","42/2914",0.10296607810546,0.179031108777962,0.0932504548039017,"MAPK3/MAPK1",2
"R-HSA-6802949","R-HSA-6802949","Signaling by RAS mutants","2/38","42/2914",0.10296607810546,0.179031108777962,0.0932504548039017,"MAPK3/MAPK1",2
"R-HSA-6802955","R-HSA-6802955","Paradoxical activation of RAF signaling by kinase inactive BRAF","2/38","42/2914",0.10296607810546,0.179031108777962,0.0932504548039017,"MAPK3/MAPK1",2
"R-HSA-9649948","R-HSA-9649948","Signaling downstream of RAS mutants","2/38","42/2914",0.10296607810546,0.179031108777962,0.0932504548039017,"MAPK3/MAPK1",2
"R-HSA-2029482","R-HSA-2029482","Regulation of actin dynamics for phagocytic cup formation","2/38","43/2914",0.10712860729457,0.185433374061454,0.0965851498383901,"MAPK3/MAPK1",2
"R-HSA-383280","R-HSA-383280","Nuclear Receptor transcription pathway","2/38","46/2914",0.119882980017397,0.204086214472933,0.106300700748105,"RARA/NR0B2",2
"R-HSA-5696399","R-HSA-5696399","Global Genome Nucleotide Excision Repair (GG-NER)","2/38","46/2914",0.119882980017397,0.204086214472933,0.106300700748105,"UBE2I/YY1",2
"R-HSA-6802952","R-HSA-6802952","Signaling by BRAF and RAF fusions","2/38","46/2914",0.119882980017397,0.204086214472933,0.106300700748105,"MAPK3/MAPK1",2
"R-HSA-110056","R-HSA-110056","MAPK3 (ERK1) activation","1/38","10/2914",0.123191937751796,0.204086214472933,0.106300700748105,"MAPK3",1
"R-HSA-1221632","R-HSA-1221632","Meiotic synapsis","1/38","10/2914",0.123191937751796,0.204086214472933,0.106300700748105,"UBE2I",1
"R-HSA-1362300","R-HSA-1362300","Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1","1/38","10/2914",0.123191937751796,0.204086214472933,0.106300700748105,"E2F4",1
"R-HSA-4755510","R-HSA-4755510","SUMOylation of immune response proteins","1/38","10/2914",0.123191937751796,0.204086214472933,0.106300700748105,"UBE2I",1
"R-HSA-5250924","R-HSA-5250924","B-WICH complex positively regulates rRNA expression","1/38","10/2914",0.123191937751796,0.204086214472933,0.106300700748105,"GSK3B",1
"R-HSA-8934903","R-HSA-8934903","Receptor Mediated Mitophagy","1/38","10/2914",0.123191937751796,0.204086214472933,0.106300700748105,"CSNK2A1",1
"R-HSA-9617629","R-HSA-9617629","Regulation of FOXO transcriptional activity by acetylation","1/38","10/2914",0.123191937751796,0.204086214472933,0.106300700748105,"SIRT1",1
"R-HSA-168643","R-HSA-168643","Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways","2/38","48/2914",0.128590493379316,0.212119360873573,0.110484859358747,"MAPK14/MAPK11",2
"R-HSA-109606","R-HSA-109606","Intrinsic Pathway for Apoptosis","2/38","49/2914",0.13300050377284,0.214796752453592,0.111879410195353,"MAPK3/MAPK1",2
"R-HSA-3000178","R-HSA-3000178","ECM proteoglycans","2/38","49/2914",0.13300050377284,0.214796752453592,0.111879410195353,"TGFB1/FMOD",2
"R-HSA-6802957","R-HSA-6802957","Oncogenic MAPK signaling","2/38","49/2914",0.13300050377284,0.214796752453592,0.111879410195353,"MAPK3/MAPK1",2
"R-HSA-163615","R-HSA-163615","PKA activation","1/38","11/2914",0.134665321486449,0.214796752453592,0.111879410195353,"PRKACA",1
"R-HSA-210745","R-HSA-210745","Regulation of gene expression in beta cells","1/38","11/2914",0.134665321486449,0.214796752453592,0.111879410195353,"PAX6",1
"R-HSA-75815","R-HSA-75815","Ubiquitin-dependent degradation of Cyclin D","1/38","11/2914",0.134665321486449,0.214796752453592,0.111879410195353,"GSK3B",1
"R-HSA-8866910","R-HSA-8866910","TFAP2 (AP-2) family regulates transcription of growth factors and their receptors","1/38","11/2914",0.134665321486449,0.214796752453592,0.111879410195353,"YY1",1
"R-HSA-8978868","R-HSA-8978868","Fatty acid metabolism","1/38","11/2914",0.134665321486449,0.214796752453592,0.111879410195353,"MAPKAPK2",1
"R-HSA-76002","R-HSA-76002","Platelet activation, signaling and aggregation","4/38","153/2914",0.135770929089642,0.215669047854328,0.112333755495437,"MAPK3/MAPK14/TGFB1/MAPK1",4
"R-HSA-8957275","R-HSA-8957275","Post-translational protein phosphorylation","2/38","50/2914",0.137445821186748,0.217434782697069,0.113253459217726,"MEN1/LTBP1",2
"R-HSA-109581","R-HSA-109581","Apoptosis","3/38","101/2914",0.14288147653585,0.222536593667912,0.115910797356344,"MAPK3/CTNNB1/MAPK1",3
"R-HSA-1483206","R-HSA-1483206","Glycerophospholipid biosynthesis","1/38","12/2914",0.145992471945806,0.222536593667912,0.115910797356344,"CSNK2A1",1
"R-HSA-418990","R-HSA-418990","Adherens junctions interactions","1/38","12/2914",0.145992471945806,0.222536593667912,0.115910797356344,"CTNNB1",1
"R-HSA-442720","R-HSA-442720","CREB1 phosphorylation through the activation of Adenylate Cyclase","1/38","12/2914",0.145992471945806,0.222536593667912,0.115910797356344,"PRKACA",1
"R-HSA-5362517","R-HSA-5362517","Signaling by Retinoic Acid","1/38","12/2914",0.145992471945806,0.222536593667912,0.115910797356344,"RARA",1
"R-HSA-8963898","R-HSA-8963898","Plasma lipoprotein assembly","1/38","12/2914",0.145992471945806,0.222536593667912,0.115910797356344,"PRKACA",1
"R-HSA-9005891","R-HSA-9005891","Loss of function of MECP2 in Rett syndrome","1/38","12/2914",0.145992471945806,0.222536593667912,0.115910797356344,"PRKACA",1
"R-HSA-9005895","R-HSA-9005895","Pervasive developmental disorders","1/38","12/2914",0.145992471945806,0.222536593667912,0.115910797356344,"PRKACA",1
"R-HSA-74751","R-HSA-74751","Insulin receptor signalling cascade","2/38","52/2914",0.146435996869559,0.222536593667912,0.115910797356344,"MAPK3/MAPK1",2
"R-HSA-74752","R-HSA-74752","Signaling by Insulin receptor","2/38","52/2914",0.146435996869559,0.222536593667912,0.115910797356344,"MAPK3/MAPK1",2
"R-HSA-418594","R-HSA-418594","G alpha (i) signalling events","5/38","217/2914",0.148355061505843,0.224568838201002,0.116969315779633,"PPP2CB/PPP2CA/MAPK1/PRKACA/PPP2R1B",5
"R-HSA-5357801","R-HSA-5357801","Programmed Cell Death","3/38","103/2914",0.149020218131721,0.224694547651735,0.117034793022856,"MAPK3/CTNNB1/MAPK1",3
"R-HSA-111931","R-HSA-111931","PKA-mediated phosphorylation of CREB","1/38","13/2914",0.157175203188418,0.233344724733575,0.121540339307643,"PRKACA",1
"R-HSA-1630316","R-HSA-1630316","Glycosaminoglycan metabolism","1/38","13/2914",0.157175203188418,0.233344724733575,0.121540339307643,"FMOD",1
"R-HSA-198323","R-HSA-198323","AKT phosphorylates targets in the cytosol","1/38","13/2914",0.157175203188418,0.233344724733575,0.121540339307643,"GSK3B",1
"R-HSA-4085377","R-HSA-4085377","SUMOylation of SUMOylation proteins","1/38","13/2914",0.157175203188418,0.233344724733575,0.121540339307643,"UBE2I",1
"R-HSA-5358351","R-HSA-5358351","Signaling by Hedgehog","2/38","55/2914",0.160147061573925,0.235941854074561,0.122893084614784,"GSK3B/PRKACA",2
"R-HSA-5696398","R-HSA-5696398","Nucleotide Excision Repair","2/38","55/2914",0.160147061573925,0.235941854074561,0.122893084614784,"UBE2I/YY1",2
"R-HSA-3108232","R-HSA-3108232","SUMO E3 ligases SUMOylate target proteins","3/38","107/2914",0.16155669683788,0.237113631100463,0.123503418435202,"RARA/PCGF2/UBE2I",3
"R-HSA-8939211","R-HSA-8939211","ESR-mediated signaling","3/38","108/2914",0.164742130221357,0.240872963126682,0.125461510655021,"MAPK3/YY1/MAPK1",3
"R-HSA-2990846","R-HSA-2990846","SUMOylation","3/38","109/2914",0.16794718367086,0.244101912222617,0.127143346698991,"RARA/PCGF2/UBE2I",3
"R-HSA-2173791","R-HSA-2173791","TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)","1/38","14/2914",0.16821530738657,0.244101912222617,0.127143346698991,"TGFB1",1
"R-HSA-168253","R-HSA-168253","Host Interactions with Influenza Factors","1/38","15/2914",0.179114555082884,0.253253546747229,0.131910082979876,"TGFB1",1
"R-HSA-392517","R-HSA-392517","Rap1 signalling","1/38","15/2914",0.179114555082884,0.253253546747229,0.131910082979876,"PRKACA",1
"R-HSA-5250913","R-HSA-5250913","Positive epigenetic regulation of rRNA expression","1/38","15/2914",0.179114555082884,0.253253546747229,0.131910082979876,"GSK3B",1
"R-HSA-6804114","R-HSA-6804114","TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest","1/38","15/2914",0.179114555082884,0.253253546747229,0.131910082979876,"E2F4",1
"R-HSA-69205","R-HSA-69205","G1/S-Specific Transcription","1/38","15/2914",0.179114555082884,0.253253546747229,0.131910082979876,"E2F4",1
"R-HSA-8876384","R-HSA-8876384","Listeria monocytogenes entry into host cells","1/38","15/2914",0.179114555082884,0.253253546747229,0.131910082979876,"CTNNB1",1
"R-HSA-9008059","R-HSA-9008059","Interleukin-37 signaling","1/38","15/2914",0.179114555082884,0.253253546747229,0.131910082979876,"SMAD3",1
"R-HSA-69620","R-HSA-69620","Cell Cycle Checkpoints","3/38","114/2914",0.18425096879378,0.259565233410216,0.135197599076497,"PPP2CB/PPP2CA/PPP2R1B",3
"R-HSA-381426","R-HSA-381426","Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)","2/38","61/2914",0.18823940984378,0.263638965616478,0.1373194503211,"MEN1/LTBP1",2
"R-HSA-3232118","R-HSA-3232118","SUMOylation of transcription factors","1/38","16/2914",0.189874695443992,0.263638965616478,0.1373194503211,"UBE2I",1
"R-HSA-5205647","R-HSA-5205647","Mitophagy","1/38","16/2914",0.189874695443992,0.263638965616478,0.1373194503211,"CSNK2A1",1
"R-HSA-8941858","R-HSA-8941858","Regulation of RUNX3 expression and activity","1/38","16/2914",0.189874695443992,0.263638965616478,0.1373194503211,"TGFB1",1
"R-HSA-2029480","R-HSA-2029480","Fcgamma receptor (FCGR) dependent phagocytosis","2/38","62/2914",0.192992603215183,0.267007687602368,0.139074088715714,"MAPK3/MAPK1",2
"R-HSA-9009391","R-HSA-9009391","Extra-nuclear estrogen signaling","2/38","63/2914",0.197762735978502,0.270601462284514,0.140945948449256,"MAPK3/MAPK1",2
"R-HSA-163359","R-HSA-163359","Glucagon signaling in metabolic regulation","1/38","17/2914",0.200497456511324,0.270601462284514,0.140945948449256,"PRKACA",1
"R-HSA-3232142","R-HSA-3232142","SUMOylation of ubiquitinylation proteins","1/38","17/2914",0.200497456511324,0.270601462284514,0.140945948449256,"UBE2I",1
"R-HSA-418592","R-HSA-418592","ADP signalling through P2Y purinoceptor 1","1/38","17/2914",0.200497456511324,0.270601462284514,0.140945948449256,"MAPK14",1
"R-HSA-5250941","R-HSA-5250941","Negative epigenetic regulation of rRNA expression","1/38","17/2914",0.200497456511324,0.270601462284514,0.140945948449256,"SIRT1",1
"R-HSA-5696394","R-HSA-5696394","DNA Damage Recognition in GG-NER","1/38","17/2914",0.200497456511324,0.270601462284514,0.140945948449256,"YY1",1
"R-HSA-9013695","R-HSA-9013695","NOTCH4 Intracellular Domain Regulates Transcription","1/38","17/2914",0.200497456511324,0.270601462284514,0.140945948449256,"SMAD3",1
"R-HSA-5610780","R-HSA-5610780","Degradation of GLI1 by the proteasome","1/38","18/2914",0.210984545449042,0.282777897719897,0.147288187795201,"PRKACA",1
"R-HSA-8939243","R-HSA-8939243","RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known","1/38","18/2914",0.210984545449042,0.282777897719897,0.147288187795201,"CSNK2A1",1
"R-HSA-421270","R-HSA-421270","Cell-cell junction organization","1/38","19/2914",0.221337648789145,0.294608042871068,0.153450057781222,"CTNNB1",1
"R-HSA-6814122","R-HSA-6814122","Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding","1/38","19/2914",0.221337648789145,0.294608042871068,0.153450057781222,"CSNK2A1",1
"R-HSA-5578775","R-HSA-5578775","Ion homeostasis","1/38","20/2914",0.231558432673777,0.305056501747706,0.158892260250373,"PRKACA",1
"R-HSA-73854","R-HSA-73854","RNA Polymerase I Promoter Clearance","1/38","20/2914",0.231558432673777,0.305056501747706,0.158892260250373,"MAPK3",1
"R-HSA-73864","R-HSA-73864","RNA Polymerase I Transcription","1/38","20/2914",0.231558432673777,0.305056501747706,0.158892260250373,"MAPK3",1
"R-HSA-5621481","R-HSA-5621481","C-type lectin receptors (CLRs)","2/38","72/2914",0.241265839134584,0.314061742877398,0.16358274581288,"RPS6KA5/PRKACA",2
"R-HSA-111465","R-HSA-111465","Apoptotic cleavage of cellular proteins","1/38","21/2914",0.241648543094785,0.314061742877398,0.16358274581288,"CTNNB1",1
"R-HSA-3781865","R-HSA-3781865","Diseases of glycosylation","1/38","21/2914",0.241648543094785,0.314061742877398,0.16358274581288,"FMOD",1
"R-HSA-4615885","R-HSA-4615885","SUMOylation of DNA replication proteins","1/38","21/2914",0.241648543094785,0.314061742877398,0.16358274581288,"UBE2I",1
"R-HSA-1500620","R-HSA-1500620","Meiosis","1/38","22/2914",0.251609606130526,0.322662152712236,0.168062370242806,"UBE2I",1
"R-HSA-432040","R-HSA-432040","Vasopressin regulates renal water homeostasis via Aquaporins","1/38","22/2914",0.251609606130526,0.322662152712236,0.168062370242806,"PRKACA",1
"R-HSA-445717","R-HSA-445717","Aquaporin-mediated transport","1/38","22/2914",0.251609606130526,0.322662152712236,0.168062370242806,"PRKACA",1
"R-HSA-9022692","R-HSA-9022692","Regulation of MECP2 expression and activity","1/38","22/2914",0.251609606130526,0.322662152712236,0.168062370242806,"PRKACA",1
"R-HSA-201451","R-HSA-201451","Signaling by BMP","1/38","23/2914",0.261443228179987,0.331964098939062,0.172907398138426,"SMAD1",1
"R-HSA-3000170","R-HSA-3000170","Syndecan interactions","1/38","23/2914",0.261443228179987,0.331964098939062,0.172907398138426,"TGFB1",1
"R-HSA-392518","R-HSA-392518","Signal amplification","1/38","23/2914",0.261443228179987,0.331964098939062,0.172907398138426,"MAPK14",1
"R-HSA-1474165","R-HSA-1474165","Reproduction","1/38","24/2914",0.271150996194224,0.340926008244203,0.177575313811407,"UBE2I",1
"R-HSA-186712","R-HSA-186712","Regulation of beta-cell development","1/38","24/2914",0.271150996194224,0.340926008244203,0.177575313811407,"PAX6",1
"R-HSA-5674400","R-HSA-5674400","Constitutive Signaling by AKT1 E17K in Cancer","1/38","24/2914",0.271150996194224,0.340926008244203,0.177575313811407,"GSK3B",1
"R-HSA-111933","R-HSA-111933","Calmodulin induced events","1/38","25/2914",0.280734477905165,0.346209292240875,0.180327174305991,"PRKACA",1
"R-HSA-111997","R-HSA-111997","CaM pathway","1/38","25/2914",0.280734477905165,0.346209292240875,0.180327174305991,"PRKACA",1
"R-HSA-380259","R-HSA-380259","Loss of Nlp from mitotic centrosomes","1/38","25/2914",0.280734477905165,0.346209292240875,0.180327174305991,"PRKACA",1
"R-HSA-380284","R-HSA-380284","Loss of proteins required for interphase microtubule organization from the centrosome","1/38","25/2914",0.280734477905165,0.346209292240875,0.180327174305991,"PRKACA",1
"R-HSA-5218920","R-HSA-5218920","VEGFR2 mediated vascular permeability","1/38","25/2914",0.280734477905165,0.346209292240875,0.180327174305991,"CTNNB1",1
"R-HSA-8948751","R-HSA-8948751","Regulation of PTEN stability and activity","1/38","25/2914",0.280734477905165,0.346209292240875,0.180327174305991,"CSNK2A1",1
"R-HSA-380320","R-HSA-380320","Recruitment of NuMA to mitotic centrosomes","1/38","26/2914",0.290195222051791,0.353360743570951,0.184052091688169,"PRKACA",1
"R-HSA-75153","R-HSA-75153","Apoptotic execution phase","1/38","26/2914",0.290195222051791,0.353360743570951,0.184052091688169,"CTNNB1",1
"R-HSA-8854518","R-HSA-8854518","AURKA Activation by TPX2","1/38","26/2914",0.290195222051791,0.353360743570951,0.184052091688169,"PRKACA",1
"R-HSA-8939902","R-HSA-8939902","Regulation of RUNX2 expression and activity","1/38","26/2914",0.290195222051791,0.353360743570951,0.184052091688169,"GSK3B",1
"R-HSA-380270","R-HSA-380270","Recruitment of mitotic centrosome proteins and complexes","1/38","27/2914",0.299534758603741,0.361313802565763,0.188194535833272,"PRKACA",1
"R-HSA-380287","R-HSA-380287","Centrosome maturation","1/38","27/2914",0.299534758603741,0.361313802565763,0.188194535833272,"PRKACA",1
"R-HSA-9616222","R-HSA-9616222","Transcriptional regulation of granulopoiesis","1/38","27/2914",0.299534758603741,0.361313802565763,0.188194535833272,"RARA",1
"R-HSA-381676","R-HSA-381676","Glucagon-like Peptide-1 (GLP1) regulates insulin secretion","1/38","28/2914",0.308754598982355,0.368976084232784,0.192185525193514,"PRKACA",1
"R-HSA-5620912","R-HSA-5620912","Anchoring of the basal body to the plasma membrane","1/38","28/2914",0.308754598982355,0.368976084232784,0.192185525193514,"PRKACA",1
"R-HSA-8957322","R-HSA-8957322","Metabolism of steroids","1/38","28/2914",0.308754598982355,0.368976084232784,0.192185525193514,"UBE2I",1
"R-HSA-2454202","R-HSA-2454202","Fc epsilon receptor (FCERI) signaling","2/38","87/2914",0.314565517938831,0.37476015408762,0.195198225881471,"MAPK3/MAPK1",2
"R-HSA-1483257","R-HSA-1483257","Phospholipid metabolism","1/38","30/2914",0.326841145472049,0.382305097430942,0.199128098198282,"CSNK2A1",1
"R-HSA-1489509","R-HSA-1489509","DAG and IP3 signaling","1/38","30/2914",0.326841145472049,0.382305097430942,0.199128098198282,"PRKACA",1
"R-HSA-168254","R-HSA-168254","Influenza Infection","1/38","30/2914",0.326841145472049,0.382305097430942,0.199128098198282,"TGFB1",1
"R-HSA-390466","R-HSA-390466","Chaperonin-mediated protein folding","1/38","30/2914",0.326841145472049,0.382305097430942,0.199128098198282,"CSNK2A1",1
"R-HSA-5696395","R-HSA-5696395","Formation of Incision Complex in GG-NER","1/38","30/2914",0.326841145472049,0.382305097430942,0.199128098198282,"UBE2I",1
"R-HSA-6791312","R-HSA-6791312","TP53 Regulates Transcription of Cell Cycle Genes","1/38","30/2914",0.326841145472049,0.382305097430942,0.199128098198282,"E2F4",1
"R-HSA-174824","R-HSA-174824","Plasma lipoprotein assembly, remodeling, and clearance","1/38","31/2914",0.335710783638505,0.389960000212828,0.203115244179575,"PRKACA",1
"R-HSA-391251","R-HSA-391251","Protein folding","1/38","31/2914",0.335710783638505,0.389960000212828,0.203115244179575,"CSNK2A1",1
"R-HSA-1474244","R-HSA-1474244","Extracellular matrix organization","3/38","157/2914",0.336416269613658,0.389960000212828,0.203115244179575,"TGFB1/LTBP1/FMOD",3
"R-HSA-388396","R-HSA-388396","GPCR downstream signalling","7/38","436/2914",0.338226968232497,0.390885059095041,0.203597071958421,"MAPK3/RPS6KA3/PPP2CB/PPP2CA/MAPK1/PRKACA/PPP2R1B",7
"R-HSA-1280218","R-HSA-1280218","Adaptive Immune System","5/38","296/2914",0.341808168410008,0.393844635839592,0.205138602250783,"PPP2CB/FBXO22/PPP2CA/PRKACA/PPP2R1B",5
"R-HSA-8853659","R-HSA-8853659","RET signaling","1/38","32/2914",0.34446659016703,0.395726499418076,0.206118792988417,"PRKACA",1
"R-HSA-1169408","R-HSA-1169408","ISG15 antiviral mechanism","1/38","34/2914",0.3616423786683,0.410570465194011,0.213850446828623,"MAPK3",1
"R-HSA-1834949","R-HSA-1834949","Cytosolic sensors of pathogen-associated DNA ","1/38","34/2914",0.3616423786683,0.410570465194011,0.213850446828623,"CTNNB1",1
"R-HSA-5687128","R-HSA-5687128","MAPK6/MAPK4 signaling","1/38","34/2914",0.3616423786683,0.410570465194011,0.213850446828623,"PRKACA",1
"R-HSA-5693565","R-HSA-5693565","Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks","1/38","34/2914",0.3616423786683,0.410570465194011,0.213850446828623,"UBE2I",1
"R-HSA-913531","R-HSA-913531","Interferon Signaling","2/38","97/2914",0.362839634929998,0.410721698190555,0.213929218310325,"MAPK3/CIITA",2
"R-HSA-416476","R-HSA-416476","G alpha (q) signalling events","3/38","165/2914",0.365610263916673,0.412647841730514,0.214932472785733,"MAPK3/RPS6KA3/MAPK1",3
"R-HSA-1169410","R-HSA-1169410","Antiviral mechanism by IFN-stimulated genes","1/38","35/2914",0.370065152838649,0.412847251432713,0.215036337670161,"MAPK3",1
"R-HSA-446728","R-HSA-446728","Cell junction organization","1/38","35/2914",0.370065152838649,0.412847251432713,0.215036337670161,"CTNNB1",1
"R-HSA-5576891","R-HSA-5576891","Cardiac conduction","1/38","35/2914",0.370065152838649,0.412847251432713,0.215036337670161,"PRKACA",1
"R-HSA-5693606","R-HSA-5693606","DNA Double Strand Break Response","1/38","35/2914",0.370065152838649,0.412847251432713,0.215036337670161,"UBE2I",1
"R-HSA-2565942","R-HSA-2565942","Regulation of PLK1 Activity at G2/M Transition","1/38","37/2914",0.386587314693503,0.430036609428508,0.223989616582615,"PRKACA",1
"R-HSA-373755","R-HSA-373755","Semaphorin interactions","1/38","38/2914",0.394689393957197,0.437787661113442,0.228026842848834,"GSK3B",1
"R-HSA-381340","R-HSA-381340","Transcriptional regulation of white adipocyte differentiation","1/38","40/2914",0.41058215572877,0.451523396328505,0.235181261790959,"TGFB1",1
"R-HSA-4086398","R-HSA-4086398","Ca2+ pathway","1/38","40/2914",0.41058215572877,0.451523396328505,0.235181261790959,"CTNNB1",1
"R-HSA-9013694","R-HSA-9013694","Signaling by NOTCH4","1/38","40/2914",0.41058215572877,0.451523396328505,0.235181261790959,"SMAD3",1
"R-HSA-8986944","R-HSA-8986944","Transcriptional Regulation by MECP2","1/38","41/2914",0.41837543272331,0.458786696111357,0.238964436752848,"PRKACA",1
"R-HSA-5617833","R-HSA-5617833","Cilium Assembly","1/38","42/2914",0.42606834381155,0.465899095499316,0.24266901347251,"PRKACA",1
"R-HSA-422356","R-HSA-422356","Regulation of insulin secretion","1/38","45/2914",0.448557385820029,0.487727185708538,0.25403843051631,"PRKACA",1
"R-HSA-512988","R-HSA-512988","Interleukin-3, Interleukin-5 and GM-CSF signaling","1/38","45/2914",0.448557385820029,0.487727185708538,0.25403843051631,"PRKACA",1
"R-HSA-372790","R-HSA-372790","Signaling by GPCR","7/38","486/2914",0.452674059601791,0.490820750017672,0.255649749804678,"MAPK3/RPS6KA3/PPP2CB/PPP2CA/MAPK1/PRKACA/PPP2R1B",7
"R-HSA-877300","R-HSA-877300","Interferon gamma signaling","1/38","47/2914",0.463070910062003,0.500687314520821,0.26078886575805,"CIITA",1
"R-HSA-5693607","R-HSA-5693607","Processing of DNA double-strand break ends","1/38","48/2914",0.470187514672273,0.506961957160607,0.264057087040294,"UBE2I",1
"R-HSA-3000171","R-HSA-3000171","Non-integrin membrane-ECM interactions","1/38","49/2914",0.477212244066011,0.511677572804112,0.266513270808796,"TGFB1",1
"R-HSA-9018519","R-HSA-9018519","Estrogen-dependent gene expression","1/38","49/2914",0.477212244066011,0.511677572804112,0.266513270808796,"YY1",1
"R-HSA-6798695","R-HSA-6798695","Neutrophil degranulation","2/38","125/2914",0.490397032884088,0.5235425492551,0.27269328308624,"MAPK14/MAPK1",2
"R-HSA-8951664","R-HSA-8951664","Neddylation","1/38","51/2914",0.490990680907633,0.5235425492551,0.27269328308624,"FBXO22",1
"R-HSA-5663205","R-HSA-5663205","Infectious disease","2/38","126/2914",0.494677603910522,0.526020812973723,0.273984115838509,"CTNNB1/TGFB1",2
"R-HSA-400253","R-HSA-400253","Circadian Clock","1/38","52/2914",0.497746655104458,0.527830244149233,0.274926579308709,"SIRT1",1
"R-HSA-1632852","R-HSA-1632852","Macroautophagy","1/38","53/2914",0.50441528791579,0.531978964851079,0.27708748919159,"CSNK2A1",1
"R-HSA-397014","R-HSA-397014","Muscle contraction","1/38","53/2914",0.50441528791579,0.531978964851079,0.27708748919159,"PRKACA",1
"R-HSA-1500931","R-HSA-1500931","Cell-Cell communication","1/38","57/2914",0.530238184876894,0.557689208072156,0.290478971207477,"CTNNB1",1
"R-HSA-114608","R-HSA-114608","Platelet degranulation ","1/38","59/2914",0.542653528123382,0.567653826167007,0.29566915952522,"TGFB1",1
"R-HSA-5693567","R-HSA-5693567","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","1/38","59/2914",0.542653528123382,0.567653826167007,0.29566915952522,"UBE2I",1
"R-HSA-9612973","R-HSA-9612973","Autophagy","1/38","61/2914",0.554749158184668,0.578738310971032,0.301442643565495,"CSNK2A1",1
"R-HSA-76005","R-HSA-76005","Response to elevated platelet cytosolic Ca2+","1/38","62/2914",0.560679593512037,0.581780438429156,0.303027171366154,"TGFB1",1
"R-HSA-983231","R-HSA-983231","Factors involved in megakaryocyte development and platelet production","1/38","62/2914",0.560679593512037,0.581780438429156,0.303027171366154,"PRKACA",1
"R-HSA-5693538","R-HSA-5693538","Homology Directed Repair","1/38","63/2914",0.56653309121419,0.586278212355704,0.305369889718951,"UBE2I",1
"R-HSA-376176","R-HSA-376176","Signaling by ROBO receptors","1/38","64/2914",0.572310622793938,0.590673530477166,0.307659242762855,"PRKACA",1
"R-HSA-202733","R-HSA-202733","Cell surface interactions at the vascular wall","1/38","69/2914",0.600091964230675,0.617694661848109,0.321733516261218,"TGFB1",1
"R-HSA-73894","R-HSA-73894","DNA Repair","2/38","157/2914",0.616093337592281,0.632478798698458,0.329434007503151,"UBE2I/YY1",2
"R-HSA-3858494","R-HSA-3858494","Beta-catenin independent WNT signaling","1/38","76/2914",0.636053405203292,0.651237704001248,0.339204803556691,"CTNNB1",1
"R-HSA-5693532","R-HSA-5693532","DNA Double-Strand Break Repair","1/38","81/2914",0.659791569676291,0.673755412420763,0.35093341634133,"UBE2I",1
"R-HSA-446652","R-HSA-446652","Interleukin-1 family signaling","1/38","82/2914",0.664354901957372,0.676625309117534,0.352428235727977,"SMAD3",1
"R-HSA-8878171","R-HSA-8878171","Transcriptional regulation by RUNX1","1/38","86/2914",0.682019567705219,0.692788297721617,0.360846918093343,"CSNK2A1",1
"R-HSA-983168","R-HSA-983168","Antigen processing: Ubiquitination & Proteasome degradation","1/38","88/2914",0.69050908900538,0.699570888073692,0.364379709904759,"FBXO22",1
"R-HSA-6785807","R-HSA-6785807","Interleukin-4 and Interleukin-13 signaling","1/38","94/2914",0.714674812982759,0.722158318877867,0.376144638411978,"TGFB1",1
"R-HSA-2219528","R-HSA-2219528","PI3K/AKT Signaling in Cancer","1/38","97/2914",0.726058488262511,0.731745630468222,0.381138302207337,"GSK3B",1
"R-HSA-157118","R-HSA-157118","Signaling by NOTCH","1/38","104/2914",0.750927713460309,0.754838795301248,0.393166648220721,"SMAD3",1
"R-HSA-983169","R-HSA-983169","Class I MHC mediated antigen processing & presentation","1/38","115/2914",0.785629731072355,0.787670327776439,0.410267337347422,"FBXO22",1
"R-HSA-382551","R-HSA-382551","Transport of small molecules","1/38","121/2914",0.802524361335078,0.802524361335078,0.418004235110444,"PRKACA",1
